IceCure Medical (ICCM) Competitors

IceCure Medical (NASDAQ:ICCM) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, community ranking, risk, earnings and media sentiment.

Do analysts recommend ICCM or SRTS?

IceCure Medical presently has a consensus target price of $2.70, suggesting a potential upside of 344.74%. Sensus Healthcare has a consensus target price of $10.00, suggesting a potential upside of 58.98%. Given IceCure Medical's higher probable upside, research analysts clearly believe IceCure Medical is more favorable than Sensus Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Sensus Healthcare	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33

Which has more volatility and risk, ICCM or SRTS?

IceCure Medical has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500.

Does the media prefer ICCM or SRTS?

In the previous week, Sensus Healthcare had 1 more articles in the media than IceCure Medical. MarketBeat recorded 2 mentions for Sensus Healthcare and 1 mentions for IceCure Medical. IceCure Medical's average media sentiment score of 1.47 beat Sensus Healthcare's score of 0.46 indicating that IceCure Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IceCure Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sensus Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has preferable valuation and earnings, ICCM or SRTS?

Sensus Healthcare has higher revenue and earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.34M	8.30	-$14.65M	-$0.33	-1.84
Sensus Healthcare	$36.37M	2.84	$490K	$0.29	21.69

Do insiders and institutionals have more ownership in ICCM or SRTS?

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Comparatively, 11.1% of Sensus Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Is ICCM or SRTS more profitable?

Sensus Healthcare has a net margin of 18.27% compared to IceCure Medical's net margin of -410.22%. Sensus Healthcare's return on equity of 13.46% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-410.22%	-111.27%	-81.41%
Sensus Healthcare	18.27%	13.46%	12.10%

Does the MarketBeat Community favor ICCM or SRTS?

Sensus Healthcare received 158 more outperform votes than IceCure Medical when rated by MarketBeat users. However, 95.65% of users gave IceCure Medical an outperform vote while only 68.18% of users gave Sensus Healthcare an outperform vote.

Company	Underperform	Outperform
IceCure Medical	Outperform Votes 22 95.65%	Underperform Votes 1 4.35%
Sensus Healthcare	Outperform Votes 180 68.18%	Underperform Votes 84 31.82%

Summary

Sensus Healthcare beats IceCure Medical on 14 of the 18 factors compared between the two stocks.